Navigation Links
Injury Lawyers Release New Informational Graphic about the Alleged Link Between Victoza and Cancer
Date:9/6/2013

(PRWEB) September 06, 2013

Victoza (liraglutide) is a once-daily injection used to control blood sugar levels in type-2 diabetes patients. This medicine increases insulin while making the stomach feel full. The FDA approved this drug in January 2010 and it earned more than $2.3 billion in sales its first year on the market (i). Victoza, like all medicines, may cause side effects. According to the product’s website, the most common Victoza side effects were headache, nausea, and diarrhea. The manufacturer also warns that this drug may cause low blood sugar, pancreatitis, and cancer (ii). People who have suffered pancreatic cancer or thyroid cancer should talk to a personal injury attorney about their legal options.

As early as 2009 the FDA was concerned about the association between Victoza and cancer. The Agency reviewed the safety of the medicine in April 2009 and discovered twenty-nine cases of growths and tumors, including five cases of prostate cancer and five cases of thyroid cancer (iii). In June 2011, the FDA released new safety information on the drug highlighting the risk of thyroid cancer and acute pancreatitis with Victoza. The Agency also noted that this medicine is not recommended as the first choice for type-2 diabetes patients (iv). The most recent warning came in March 2013 when the FDA warned that the clinical trials had linked the drug to an “increased risk of pancreatitis, or inflammation of the pancreas, and pre-cancerous cellular changes called pancreatic duct metaplasia.” Read the Drug Safety Communication here.

The Victoza infographic provides important information to type-2 diabetes patients, who are using the drug. Patients who have suffered Victoza side effects like cancer may be able to recover damages for medical bills, lost income, pain and suffering, and other injuries. d’Oliveira & Associates has been investigating these cases and the law firm is ready to answer any questions. They also work with some of the more experienced Victoza lawyers, who are handling these cases, and there are no legal fees unless you receive a settlement or award. Contact the law firm online or call 1-800-992-6878 for a free legal consultation.

(i) Novo Nordisk 2012 Annual Report.
webmedia.novonordisk.com/nncom/images/annual_report/2012/Novo-Nordisk-AR-2012-en.pdf
(ii) Product Website: Understanding Side Effects.
victoza.com/learn/usage-guidelines.aspx
(iii) Endocrine and Metabolic Drug Advisory Committee, April 2009.
fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM148659.pdf%20FDA%20April%202009
(iv) Drug Safety Communication, March 2013.
fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm258826.htm

Read the full story at http://www.prweb.com/releases/2013/9/prweb11070331.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
2. Why is traumatic brain injury increasing among the elderly?
3. Long-term neuropsychological impairment is common in acute lung injury survivors
4. Experts Offer Advice After Yankee Pitchers Trampoline Injury
5. Spinal cord injury researchers win Apple Award for article on niacin for dyslipidemia
6. Mild traumatic brain injury may contribute to brain network dysfunction
7. Injury-Linked Deaths Vary Widely Among States
8. Most occupational injury and illness costs are paid by the government and private payers
9. Diabetes drug could be a promising therapy for traumatic brain injury
10. Brain-Injury Recovery Varies Widely Among Children
11. Traumatic brain injury the focus of American Headache Society scientific conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... On Saturday, ... a treadmill relay – Miles by Moonlight to raise money for the American Heart ... or more. , Teams will work together to keep their treadmills moving for ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... wound care advancements to physician colleagues, skilled nursing facility medical directors and other ... Treacherous Waters of Wound Care." , "At many of these conferences we get ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE ... team that developed an innovative way to use nonlinear ... the delivery of new drugs. ... Clinical Dermatology Conference will show how researchers from BioPharmX ... Harvard Medical School used a suite of imaging techniques ...
(Date:10/10/2017)...   West Pharmaceutical Services, Inc. (NYSE: WST), ... administration, today shared the results of a study highlighting ... intradermal administration of polio vaccines. The study results were ... 2017 by Dr. Ondrej Mach , Clinical Trials ... (WHO), and recently published in the journal Vaccine. ...
(Date:10/4/2017)... , Oct. 4, 2017 OBP ... self-contained, illuminating medical devices, today announced regulatory approval ... Surveillance Agency (or Agência Nacional de Vigilância Sanitária ... single-use, cordless surgical retractor with integrated LED light ... access, illumination and exposure of a tissue pocket ...
Breaking Medicine Technology: